Related Experiment Video
Updated: Dec 15, 2025
15:48
Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014
22.9K
Mammographic density and breast cancer screening
1Women's Health Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Summary
High mammographic density, a measure of breast tissue composition, is linked to lower breast cancer detection rates and increased cancer risk. Research is exploring supplementary imaging for high-risk women.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Mammographic density, influenced by fibroglandular tissue and fat, varies among women and is associated with factors like age and BMI.
- Digital mammography has enabled automated assessment of mammographic density, replacing subjective visual inspection.
- High mammographic density is a significant concern due to decreased sensitivity in breast cancer detection and an elevated risk of developing breast cancer.
Purpose of the Study:
- To explore the implications of mammographic density in breast cancer screening and risk assessment.
- To address the ongoing debate regarding the utility of supplementary imaging for women with high mammographic density.
Main Methods:
- Review of mammographic density assessment, its relationship with breast cancer risk factors, and screening outcomes.
- Discussion of the challenges and controversies surrounding supplementary imaging in high mammographic density cases.
Main Results:
- Mammographic density is a key factor influencing breast cancer detection sensitivity and risk.
- The role of mammographic density in the causal pathway of breast cancer is complex and varies.
- The necessity and optimal approach for supplementary imaging in high-density breasts remain under investigation.
Conclusions:
- Mammographic density is a critical factor in breast cancer risk stratification and screening effectiveness.
- Further research and clinical trials are essential to determine the benefits and risks of supplementary imaging for women with high mammographic density.
